Showing 1 - 3 results of 3 for search 'Eva Tsalikian', query time: 0.02s
Refine Results
-
1
Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells. by Sushmita Sinha, Pranav S Renavikar, Michael P Crawford, Scott M Steward-Tharp, Ashley Brate, Eva Tsalikian, Michael Tansey, Ezzatollah T Shivapour, Tracey Cho, John Kamholz, Nitin J Karandikar
Published 2020-01-01
Article -
2
A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes by Allan L. Reiss, Booil Jo, Ana Maria Arbelaez, Eva Tsalikian, Bruce Buckingham, Stuart A. Weinzimer, Larry A. Fox, Allison Cato, Neil H. White, Michael Tansey, Tandy Aye, William Tamborlane, Kimberly Englert, John Lum, Paul Mazaika, Lara Foland-Ross, Matthew Marzelli, Nelly Mauras, the Diabetes Research in Children Network (DirecNet) Consortium
Published 2022-08-01
Article -
3
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes by Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J. Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James G. McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team
Published 2021-11-01
Article